Skip to search.
 BSE Down 0.37% NSE Down 0.44%
Streaming
Ticker Tape: On

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM

10.28 Up 0.12(1.18%) 18 Jun 1:30AM

Add to Portfolio
Prev Close:10.16
Open:10.24
Bid:9.99 x 100
Ask:15.88 x 200
1y Target Est:8.50
Beta:1.73
Next Earnings Date:29-Jul-13OSIR Earnings announcement
Day's Range:10.10 - 10.29
52wk Range:6.55 - 14.46
Volume:23,267
Avg Vol (3m):111,030
Market Cap:338.53M
P/E (ttm):N/A
EPS (ttm):-0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for OSIR at this time.

Comparison

Symbol% ChgMkt Cap
OSIRUp 1.18%338.53M
RHHBYN.MXDown 1.23%2.69T
SHP.LUp 0.62%11.55B
SUNPHARMA.NSDown 0.24%1.00T
GILD.MXDown 3.67%996.82B
» More Competitors

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):29.19
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est (Dec-13) :-0.31
Quarterly EPS Est (Jun-13) :-0.09
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing of therapeutic products to treat medical conditions in the inflammatory, cardiovascular, orthopedic, and wound healing markets. View More
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback